跳至主要内容
临床试验/JPRN-jRCT2080222175
JPRN-jRCT2080222175未知3 期

A multicenter double blind randomized controlled trial to investigate the efficacy of S-555739 in perennial allergic rhinitis

SHIONOGI & CO., LTD.0 个研究点开始时间: 2013年8月20日最近更新:
适应症

试验速览

阶段
3 期

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 16age old 至 <= 64age old(—)
性别
All

入选标准

  • Patients with perennial allergic rhinitis

排除标准

  • 未提供

研究者

相似试验

尚未招募
1 期
A multicenter randomized double-blind controlled study on the staged prevention and treatment of early retinal degeneration in high myopia by combining disease and syndromeRetinal degeneration of high myopia
ITMCTR2200006531Eye Hospital of China Academy of Chinese Medical Sciences
进行中(未招募)
1 期
AMIKINHAL (AMIKACIN inhaled)Patient with mechanical ventilation through an endotracheal tubeMedDRA version: 19.1Level: LLTClassification code 10065153Term: Ventilator associated pneumoniaSystem Organ Class: 100000004862
EUCTR2016-001054-17-FRCHRU de Tours850
进行中(未招募)
1 期
A clinical trial to evaluate the effect of the anti-viral drug Valganciclovir in brain tumor patientsGlioblastoma is an incurable brain tumor with very dismal prognosis. Substantial evidence demonstrates that cytomegalovirus (CMV) is present in 90-100% of malignant glioblastoma.We have observed that valganciclovir is well tolerated among glioblastoma patients receiving temozolomide and radiation therapy. We further observed that treatment with valganciclovir may enhance the survival chances for glioblastoma patients. We aim to assess the efficacy of Valganciclovir in glioblastoma patients.
EUCTR2019-001083-30-SEKarolinska Institutet220
尚未招募
2 期
idocaine (lignocaine) for Neuropathic Cancer Pain – Feasibility study (LiCPain)europathic Cancer Pain
ACTRN12617000747325niversity of Technology Sydney36
进行中(未招募)
1 期
A multicentre double-blind randomised controlled trial to assess the clinical- and cost-effectiveness of facet- joint injections in selected patients with non-specific low back pain: A feasibility study.on-specific low back pain of more than three months' duration
EUCTR2014-003187-20-GBBarts Health NHS Trust16